New fronts in the adjuvant treatment of GIST Peter ReichardtHeikki JoensuuJean-Yves Blay Review Article 11 August 2013 Pages: 715 - 723
Receptor tyrosine kinase alterations and therapeutic opportunities in squamous cell carcinoma of the lung Dong WangLicheng DuZhou Wang Review Article 20 August 2013 Pages: 725 - 731
Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model Yuliang SunNandini DeyBrian Leyland-Jones Original Article 20 August 2013 Pages: 733 - 745
A clinical investigation of inhibitory effect of panobinostat on CYP2D6 substrate in patients with advanced cancer Ronald FeldMargaret M. WooAsha Nayak Original Article 08 September 2013 Pages: 747 - 755
Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis Kazuma HamadaNaoko KakigawaToshiharu Horie Original Article 21 August 2013 Pages: 757 - 765
Effects of pemetrexed, gefitinib, and their combination on human colorectal cancer cells Guanzhong ZhangXiaodong XieShunchang Jiao Original Article 20 August 2013 Pages: 767 - 775
Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma Sheng-hua ZhangHao ZhangRong-guang Shao Original Article 23 August 2013 Pages: 777 - 788
Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins Yunhui HuXin ChengDongsheng Xiong Original Article 08 September 2013 Pages: 789 - 798
Identification of two novel inhibitors of mTOR signaling pathway based on high content screening Juming YanHongyu ZhouYan Li Original Article 10 August 2013 Pages: 799 - 808
A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer Chang Dong YeoSang Haak LeeChi Hong Kim Original Article 06 August 2013 Pages: 809 - 814
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma Inkeun ParkMin-Hee RyuYoon-Koo Kang Original Article 07 August 2013 Pages: 815 - 823
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients Hye Ryun KimHyung Soon ParkSun Young Rha Original Article 08 September 2013 Pages: 825 - 835
Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy Takahide TaguchiGoshi NishimuraNobuhiko Oridate Original Article 20 August 2013 Pages: 837 - 843
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer Hunho SongBoram HanDae Young Zang Original Article 27 August 2013 Pages: 845 - 852
Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma Ki Hyang KimSang Hyun YoonSun Young Rha Original Article 27 August 2013 Pages: 853 - 860
A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors Kyriakos P. PapadopoulosHoward A. Burris IIIJeffery R. Infante Original Article Open access 25 August 2013 Pages: 861 - 868
Reversibility of regorafenib effects in hepatocellular carcinoma cells Rosalba D’AlessandroMaria G. RefoloBrian I. Carr Original Article 20 August 2013 Pages: 869 - 877
Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib Massimo ZucchettiKatiuscia BonezziGiulia Taraboletti Original Article 24 August 2013 Pages: 879 - 887
Clinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer Jin HuangTengyue ZhangXianhai Zhu Original Article Open access 22 August 2013 Pages: 889 - 896
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias Ivana GojoMariola SadowskaRajat Bannerji Clinical Trial Report Open access 15 August 2013 Pages: 897 - 908
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC) Hielke J. MeulenbeldJohann S. de BonoRonald de Wit Clinical Trial Report 07 August 2013 Pages: 909 - 916
Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas Shivaani KummarMartin E. GutierrezJerry M. Collins Short Communication 03 August 2013 Pages: 917 - 923
Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio Jun ChenRong-Rong HuBao-Chang Cai Short Communication 11 August 2013 Pages: 925 - 929
Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers Jamie E. ChaftNatasha RekhtmanChristopher G. Azzoli Short Communication 22 August 2013 Pages: 931 - 934